Oyster Point Pharma, Inc.
USD11.17
+0.00 (+0.00%)
CEO
Jeffrey Nau
IPO Date
2019-10-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.16
Prev. Close
$11.17
Day Low
$11.12
Day High
$11.20
52W Low
$3.46
52W High
$13.45
Volume
2.09M
| -6.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -33.3% | -31.9% | 0.01 | 26.33 | -2.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 43.2% | -289.3% | -0.00 | 5.98 | -10.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 30.1% | -28.5% | 0.00 | 11.21 | -25.7 |
| -0.5 |
| 31 Mar 2022 | Q1 | 87.6% | -1884.5% | -91.0% | -28.8% | 1.67 | 7.27 | -1.5 |
| 31 Dec 2021 | Q4 | 76.9% | -677.3% | -44.9% | -20.1% | 0.93 | 7.47 | -2.7 |
| 30 Sept 2021 | Q3 | 100.0% | -98.5% | -12.8% | -9.1% | 0.31 | 12.51 | -4.4 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -14.5% | -13.6% | 0.01 | 16.78 | -5.1 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -11.1% | -10.2% | 0.01 | 13.30 | -6.3 |
| 31 Dec 2020 | Q4 | 0.0% | 0.0% | -11.9% | -11.2% | 0.00 | 17.88 | -5.5 |
| 30 Sept 2020 | Q3 | 0.0% | 0.0% | -7.9% | -7.5% | 0.00 | 22.78 | -8.3 |
| 30 Jun 2020 | Q2 | 0.0% | 0.0% | -7.0% | -6.7% | 0.00 | 26.32 | -10.9 |